Total Payments
$2.3M
2024 Payments
$318,255
Companies
64
Transactions
3,693
Medicare Patients
8,020
Medicare Billing
$2.2M
Payment Breakdown by Category
Other$2.0M (87.1%)
Travel$138,000 (5.9%)
Food & Beverage$110,893 (4.8%)
Consulting$50,775 (2.2%)
Education$707.70 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.8M | 948 | 78.5% |
| Honoraria | $191,575 | 93 | 8.2% |
| Travel and Lodging | $138,000 | 413 | 5.9% |
| Food and Beverage | $110,893 | 2,177 | 4.8% |
| Consulting Fee | $50,775 | 39 | 2.2% |
| Compensation for serving as faculty or as a speaker for a medical education program | $4,000 | 1 | 0.2% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $3,500 | 1 | 0.2% |
| Education | $707.70 | 21 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $392,977 | 458 | $0 (2024) |
| ABBVIE INC. | $259,484 | 274 | $0 (2024) |
| Amgen Inc. | $240,160 | 263 | $0 (2023) |
| SK Life Science, Inc. | $203,967 | 205 | $0 (2024) |
| Eisai Inc. | $143,703 | 243 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $143,280 | 256 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $130,832 | 164 | $0 (2018) |
| Depomed, Inc. | $115,778 | 148 | $0 (2017) |
| Allergan, Inc. | $104,983 | 177 | $0 (2021) |
| Alkermes, Inc. | $103,606 | 104 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $318,255 | 556 | Otsuka America Pharmaceutical, Inc. ($59,955) |
| 2023 | $296,077 | 499 | AbbVie Inc. ($80,751) |
| 2022 | $338,615 | 447 | SK Life Science, Inc. ($81,909) |
| 2021 | $289,273 | 353 | Teva Pharmaceuticals USA, Inc. ($76,502) |
| 2020 | $188,899 | 266 | Teva Pharmaceuticals USA, Inc. ($52,123) |
| 2019 | $224,666 | 389 | Amgen Inc. ($83,167) |
| 2018 | $317,791 | 579 | Assertio Therapeutics, Inc. ($90,789) |
| 2017 | $353,412 | 604 | ACADIA Pharmaceuticals Inc ($130,725) |
All Payment Transactions
3,693 individual payment records from CMS Open Payments — Page 1 of 148
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Bausch Health US, LLC | APLENZIN (Drug) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: Neurology | ||||||
| 12/31/2024 | Bausch Health US, LLC | APLENZIN (Drug) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: Neurology | ||||||
| 12/20/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $30.56 | General |
| Category: Central Nervous System | ||||||
| 12/19/2024 | Neurelis, Inc. | VALTOCO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,272.00 | General |
| Category: EPILEPSY | ||||||
| 12/19/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $13.04 | General |
| Category: Central Nervous System | ||||||
| 12/19/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $3.32 | General |
| Category: Central Nervous System | ||||||
| 12/19/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $0.46 | General |
| Category: Central Nervous System | ||||||
| 12/18/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: Analgesic | ||||||
| 12/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.49 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/16/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/16/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | Cash or cash equivalent | $120.78 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/16/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $25.37 | General |
| Category: PSYCHIATRY | ||||||
| 12/16/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 12/12/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $25.31 | General |
| Category: PAIN | ||||||
| 12/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $8.64 | General |
| Category: Central Nervous System | ||||||
| 12/11/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,550.00 | General |
| Category: CNS | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $128.96 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: EPILEPSY | ||||||
| 12/09/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 12/09/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $9.37 | General |
| Category: CNS | ||||||
| 12/05/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $600.00 | General |
| Category: ANTI-ANXIETY | ||||||
| 12/05/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $600.00 | General |
| Category: ANTI-ANXIETY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 2,725 | 8,652 | $2.9M | $781,334 |
| 2022 | 14 | 2,366 | 7,259 | $2.2M | $623,002 |
| 2021 | 12 | 1,590 | 5,275 | $1.7M | $443,280 |
| 2020 | 11 | 1,339 | 3,876 | $1.3M | $311,893 |
Total Patients
8,020
Total Services
25,062
Medicare Billing
$2.2M
Procedure Codes
51
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 526 | 3,500 | $1.2M | $283,313 | 24.0% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 435 | 3,181 | $604,135 | $192,134 | 31.8% |
| 95812 | Measurement of brain wave activity (eeg), 41-60 minutes | Office | 2023 | 271 | 273 | $245,700 | $89,205 | 36.3% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 257 | 262 | $209,600 | $42,332 | 20.2% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 220 | 222 | $83,250 | $39,846 | 47.9% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 291 | 418 | $209,000 | $38,062 | 18.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 180 | 180 | $123,090 | $27,479 | 22.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 112 | 175 | $67,900 | $20,055 | 29.5% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 154 | 156 | $124,800 | $19,285 | 15.5% |
| 92546 | Test for abnormal eye movement using a rotating chair | Office | 2023 | 82 | 84 | $13,440 | $10,224 | 76.1% |
| 92540 | Evaluation and testing for balance with recording | Office | 2023 | 82 | 84 | $12,600 | $8,364 | 66.4% |
| 93886 | Complete ultrasound of within the brain blood flow | Office | 2023 | 19 | 19 | $8,455 | $4,922 | 58.2% |
| 92537 | Test to assess balance during warm and cool irrigation in both ears | Office | 2023 | 82 | 84 | $6,300 | $3,086 | 49.0% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 14 | 14 | $4,550 | $3,028 | 66.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 419 | 2,831 | $849,700 | $192,638 | 22.7% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 377 | 2,658 | $465,310 | $154,539 | 33.2% |
| 95812 | Measurement of brain wave activity (eeg), 41-60 minutes | Office | 2022 | 222 | 229 | $206,100 | $77,701 | 37.7% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 238 | 399 | $184,500 | $38,571 | 20.9% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 196 | 200 | $171,900 | $33,855 | 19.7% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2022 | 167 | 167 | $62,625 | $30,772 | 49.1% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2022 | 164 | 166 | $132,800 | $21,647 | 16.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 142 | 142 | $63,900 | $21,532 | 33.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 88 | 111 | $38,850 | $11,984 | 30.8% |
| 92540 | Evaluation and testing for balance with recording | Office | 2022 | 107 | 108 | $16,200 | $11,192 | 69.1% |
| 92546 | Test for abnormal eye movement using a rotating chair | Office | 2022 | 83 | 84 | $13,440 | $10,339 | 76.9% |
About Dr. Idan Sharon, M.D
Dr. Idan Sharon, M.D is a Specialist healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1205852845.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Idan Sharon, M.D has received a total of $2.3M in payments from pharmaceutical and medical device companies, with $318,255 received in 2024. These payments were reported across 3,693 transactions from 64 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($1.8M).
As a Medicare-enrolled provider, Sharon has provided services to 8,020 Medicare beneficiaries, totaling 25,062 services with total Medicare billing of $2.2M. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Brooklyn, NY
- Active Since 07/15/2006
- Last Updated 05/01/2024
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1205852845
Products in Payments
- Aimovig (Biological) $239,155
- VRAYLAR (Drug) $205,582
- AUSTEDO (Drug) $203,164
- XCOPRI (Drug) $183,051
- REXULTI (Drug) $143,490
- NUPLAZID (Drug) $130,832
- Fycompa (Drug) $126,382
- UBRELVY (Drug) $121,876
- Gralise (Drug) $109,387
- LYBALVI (Drug) $103,586
- NURTEC ODT (Drug) $98,699
- Austedo XR (Drug) $73,452
- AJOVY (Biological) $61,522
- AJOVY (Drug) $53,507
- Cambia (Drug) $51,393
- Nucynta (Drug) $45,743
- QULIPTA (Drug) $36,967
- Auvelity (Drug) $36,465
- VALTOCO (Drug) $28,208
- APTIOM (Drug) $27,804
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Brooklyn
Dr. Sean Studer, M.d, M.D
Specialist — Payments: $411,591
Specialist $411,591
Dr. Michael Lewis, M.d, M.D
Specialist — Payments: $68,268
Specialist $68,268
Dr. Marc Avram, Md, MD
Specialist — Payments: $48,018
Specialist $48,018
Michael Amoashiy, Md, MD
Specialist — Payments: $41,408
Specialist $41,408
Dr. Madhavi Reddy, M.d, M.D
Specialist — Payments: $40,649
Specialist $40,649
Mr. Benjamin Wu
Specialist — Payments: $23,392
Specialist $23,392